Verweise von anderen Artikeln
- Abcd rule
- Ain
- Albinism oculocutaneous tyrosinase-negative
- Alopecia neoplastica
- Amalgam tattoo
- Acute anal venous thrombosis
- Angiogenesis
- Angiogenesis
- Angiokeratoma circumscriptum
- Angiokeratome, solitary
- Cherry angioma
- Antisense molecules
- Reflected light microscopy
- Incident light microscopy, basic architecture of polymorphic and/or aneurysmatic vessels
- Incident light microscopy, bluish-white opaque veil
- Reflected light microscopy, brown/black dot against blue-grey background
- Reflected light microscopy, grey-blue follicular pigment ring
- Reflected light microscopy, melanophagous pseudotrabelly or diffusely distributed melanophagous trabecula
- Reflected light microscopy, melanophagus-fringed regression zones
- Reflected light microscopy, perivascular melanophages
- Reflected light microscopy, pseudopodia-like marginal zone
- Reflected light microscopy, radial streaming
- Reflected light microscopy, zonally superimposed spots
- BAP1 Gene
- Bap1 Tumor Predisposition Syndrome
- Basal cell carcinoma pigmented
- Narcotics
- Betulin
- Bevacizumab
- Bhd scheme
- Occupational skin disease according to bk 5103
- Black heel
- Blue nevus
- Blue nevus, malignant
- BMI1 gene
- Bold scheme
- BRAF Gene
- Luxurious caro
- Catenine
- CCL12
- Ccl8
- CCR7
- Cd10
- Cd30
- CD classification
- Cisplatin
- Combined nevus
- Cxcl3
- Cycline D1
- CYSLTR2 gene
- Dacarbazine
- Dbctii schema
- Dbct scheme
- Dermatofibroma
- Dermatofibroma hemosiderin storing
- Driver mutation
- Dtic-il2 scheme
- Dtic-inf-alpha scheme
- Dvp scheme
- EDNRB gene
- Electrochemotherapy
- Elesclomol
- Encorafenib
- EPHA3 gene
- Epidermal-melanin unit
- Epidermolysis bullosa dystrophica recessive, severe generalized
- Erysipelas melanomatosum
- Limb perfusion, hyperthermic
- FCGR1A gene
- Fibroxanthoma atypical
- Fotemustin
- Foxp3 Gene
- Fumaric acid ester
- Gangliosides
- Gemmangioma
- GNAQ gene
- Pyogenic granuloma
- Skin cancer, black
- Skin cancer (overview)
- Skin metastases
- Hbm45
- Heat-shock proteins
- Hutchinson sign i
- Hydroxycarbamide
- Immune checkpoint inhibitors
- Interferon alpha-2a
- Interferon alpha-2b
- Interleukin-2 therapy
- Interleukin-9
- Ipilimumab
- Irinotecan
- JAK2-gene
- Keratosis seborrhoeic (overview)
- Clear cell sarcoma
- Lag3
- LAMP2
- Lentigo maligna
- Lentigo maligna melanoma
- Lentigo, reticular
- Levamisole
- Light protection
- Li-Fraumeni syndrome
- Lung diseases, skin changes
- Mage-a3
- Mart1
- Matrix metalloproteinases
- Mc1r
- Melanoacanthoma
- Melanoderma, diffuse
- Melanoma
- Melanoma acrolentiginous
- Melanoma amelanotic
- Melanoma anorectal
- Melanoma desmoplastic
- Juvenile melanoma
- Melanoma nodular
- Melanoma primary dermal
- Melanoma spitzoides
- Melanoma superficial spreading
- Melanoma unclassifiable
- Melanonychia striata
- Melanonychia
- Melanosarcoma
- Melanotic spots of the mucous membranes
- Melanuria
- Melphalan
- Membranoproliferative glomerulonephritis
- Methoxsalen
- Methylthioadenosine phosphorylase
- Microscopically controlled surgery
- Mistletoe preparations
- Navel concretion formation
- Nevocarcinomas
- Nevus melanocytic acral
- Nevus melanocytic dysplastic
- Naevus melanocytic common
- Nevus, melanocytic, recurrent
- Nevus, melanocytic, subungual
- Nevus spitz
- Neurofibroma, pigmented
- Nras
- Oncogenes
- Papillomatosis cutis carcinoides
- Parkinson disease and skin
- Pheonychia
- Phlda1
- POU3F2 gene
- Puva therapy
- Raf-kinasen
- Rehabilitation, dermatological
- Rituximab
- RNAI therapy
- X-ray surface irradiation
- Mucous membrane melanoma
- Sentinel lymph node dissection
- Sonography, 20 mhz sonography
- Spindle cell tumor, pigmented
- SPRED1 protein
- Talimogen laherparepvec
- Tamoxifen
- T cell receptor-engineered T cells
- Temozolomide
- Tert
- Thalidomide
- Tinea nigra palmaris et plantaris
- Topoisomerase inhibitors
- Tremelimumab
- Tumor-infiltrating lymphocytes
- Tumor, malignant
- Tyrosine kinase inhibitors
- Neoplastic leg ulcer
- Venous leg ulcer
- Uva-1 therapy
- Uveal melanoma
- Uv rays
- Vbc scheme
- Vegf
- Vemurafenib
- Vinblastine
- Vincrist
- Vindesin
- Xeroderma pigmentosum
Zurück zum Artikel